Quantum Biopharma (QNTM) Net Cash Flow (2019 - 2026)

Quantum Biopharma (QNTM) has 7 years of Net Cash Flow data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow rose 198.34% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 million (down 63.84% YoY), and the FY2025 full-year result was -$4.1 million, down 226.3% from the prior year.
• Net Cash Flow improved to $2.4 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $9.7 million in Q2 2022 to a low of -$42.5 million in Q4 2022.
• A 4-year average of -$1.0 million and a median of $1.5 million in 2025 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow plunged 153.26% in 2025 and soared 198.34% in 2026, its largest moves.
• Tracing QNTM's Net Cash Flow over 4 years: stood at -$42.5 million in 2022, then jumped by 106.76% to $2.9 million in 2024, then slumped by 49.25% to $1.5 million in 2025, then soared by 66.95% to $2.4 million in 2026.
• Business Quant data shows QNTM's Net Cash Flow at $2.4 million in Q1 2026, $1.5 million in Q4 2025, and -$1.5 million in Q3 2025.